CHMP5 and COVID-19: In the case of COVID-19, the hypothesis that antibodies against spike protein, whether elicited by natural infection or by vaccination are a correlate of protection against COVID-19 is supported by diverse lines of evidence19, including evidence supporting a mechanistic correlate of protection that can be derived from passive transfer of antibodies in experimental challenge studies and from studies of human monoclonal antibodies20–22.